Brief: PharmaSGP Holding H1 Adjusted EBITDA EUR 16.9 Million
12/09/2024 07:16
Sep 12 (Reuters) - PharmaSGP Holding H1 EBITDA margin 28.9%. * H1 EBITDA EUR 16.8 million * H1 revenue EUR 58.4 million * H1 adjusted EBITDA margin 28.9% * outlook FY revenue EUR 107-112 million
Recent news on PharmaSGP Holding SE
See all newsBrief: PharmaSGP Holding Outlook FY Revenue EUR 132-138 Million
Brief: PharmaSGP Holding Outlook FY Adjusted EBITDA EUR 37-39 Million
Brief: PharmaSGP Holding Q1 Adjusted EBITDA EUR 9.2 Million
Brief: PharmaSGP Holding Outlook FY Revenue EUR 122-128 Million
Brief: PharmaSGP Holding 9M Adjusted EBITDA EUR 27 Million